EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of Seroprevalence and Risk Factors of Hepatitis D in Provinces with Common Borders of Iran and Afghanistan

Arezou Khosrojerdi, Davod Javanmard, Abdol Sattar Pagheh, Sayed Hamid Mousavi, Effat Alemzadeh, Parvin Askari, Motahare Mahi-Birjand, Arash Ziaee, Nima Hoseinizadeh, Masood Ziaee

Hepatitis Monthly · 30.03.2025 · 25 (1)

DOI: 10.5812/hepatmon-149232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatitis Monthly, online erschienen am 30.03.2025. Verfasst von Arezou Khosrojerdi und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis D virus (HDV) relies on hepatitis B surface antigen (HBsAg) for infection, often causing more severe disease than hepatitis B virus (HBV) alone. While HDV seroprevalence is well-documented in regions like the Mediterranean and Middle East, limited data exist for Afghanistan, where migration patterns may influence prevalence.

Objectives

This study investigated HDV seroprevalence among HBV-infected individuals in the border provinces of eastern Iran and western Afghanistan.

Methods

A cross-sectional study was conducted on 350 HBsAg-positive patients from three Iranian provinces (Razavi Khorasan, South Khorasan, Sistan, and Baluchestan) and three Afghan provinces (Herat, Farah, Nimroz). Risk factor data were collected via questionnaire, and serum samples were tested for anti-HDV antibodies. The HDV seroprevalence was analyzed across various demographic categories, and the relationship between categorical variables (age, gender, marital status, living status) and HDV status was assessed using the chi-square or Fisher's exact test.

Results

Of the participants, 57.14% were men, and 42.86% were women. HDV antibodies were detected in 37 patients (10.57%). Seroprevalence in Iranian provinces was 4.6% in Mashhad, 2.7% in Birjand, and 13% in Zahedan, compared to 17.3% in Afghanistan’s border provinces. No significant differences in age, gender, or marital status were observed between HDV-positive and HDV-negative groups (P > 0.05). However, a significant difference was observed between the place of residence in the HDV-positive and HDV-negative groups (P = 0.004).

Conclusions

The HDV seroprevalence is significantly higher in the western provinces of Afghanistan than in eastern Iran, underscoring the importance of routine HDV screening among HBV-infected patients in these regions to improve disease management and public health outcomes.

Zitieren

APA

Khosrojerdi, A., Javanmard, D., Pagheh, A. S., Mousavi, S. H., Alemzadeh, E., Askari, P., Mahi-Birjand, M., Ziaee, A., Hoseinizadeh, N., & Ziaee, M. (2025). Investigation of Seroprevalence and Risk Factors of Hepatitis D in Provinces with Common Borders of Iran and Afghanistan. Hepatitis Monthly, 25(1). https://doi.org/10.5812/hepatmon-149232

Vancouver

Khosrojerdi A, Javanmard D, Pagheh AS, Mousavi SH, Alemzadeh E, Askari P, et al. Investigation of Seroprevalence and Risk Factors of Hepatitis D in Provinces with Common Borders of Iran and Afghanistan. Hepatitis Monthly. 2025;25(1). doi:10.5812/hepatmon-149232

BibTeX
@article{Khosrojerdi2025,
  author = {Khosrojerdi, Arezou and Javanmard, Davod and Pagheh, Abdol Sattar and Mousavi, Sayed Hamid and Alemzadeh, Effat and Askari, Parvin and Mahi-Birjand, Motahare and Ziaee, Arash and Hoseinizadeh, Nima and Ziaee, Masood},
  title = {Investigation of Seroprevalence and Risk Factors of Hepatitis D in Provinces with Common Borders of Iran and Afghanistan},
  journal = {Hepatitis Monthly},
  year = {2025},
  volume = {25},
  number = {1},
  doi = {10.5812/hepatmon-149232}
}
Kostenlos starten →